fourteen boys ( mean age , 9.2 +/- 1.5 years ) with attention deficit disorder ( add ) with hyperactivity were treated with dextroamphetamine sulfate or a monoamine oxidase inhibitor ( maoi ) ( six received clorgyline , eight received tranylcypromine sulfate ) for four weeks each in a double-blind , cross-over study that included a two-week placebo washout between active drug periods .
C1263846
with attention deficit disorder
C0011810
dextroamphetamine sulfate